The BRAIN TRIAL: a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury
31 March 2025
Want to hear from us?
Sign up to our trial newsletters and get the latest information on our trials.